Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.

Cancer research - 1 May 2003

Kibel Adam S, Suarez Brian K, Belani Jay, Oh Joe, Webster Raul, Brophy-Ebbers Michele, Guo Chan, Catalona William J, Picus Joel, Goodfellow Paul J

Abstract excerpt

A multigenic model of prostate cancer susceptibility has been proposed, in which common polymorphic variants of genes, such as the androgen and vitamin D receptor, contribute to tumorigenesis. The discovery of additional genetic factors that contribute to prostate cancer risk should provide opportunities for new approaches to the detection and treatment of this common malignancy. Herein, we examined single...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Cycle Proteins

Share to Cyclin-Dependent Kinase Inhibitor p21

Share to Cyclin-Dependent Kinase Inhibitor p27

Share to Cyclins

Share to Prostatic Neoplasms

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 12727815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.PMID 12727815Read ↗

A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.Semantic proximity Read ↗

Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.Semantic proximity Read ↗

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.Semantic proximity Read ↗

Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?Semantic proximity Read ↗

Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.Semantic proximity Read ↗

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.Semantic proximity Read ↗

Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.Semantic proximity Read ↗

Clinical Predictors of Germline DNA Damage Repair Gene Mutations in Patients with Advanced Prostate CancerSemantic proximity Read ↗

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.Semantic proximity Read ↗

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.Semantic proximity Read ↗

Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.Semantic proximity Read ↗

Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.